VLU Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about VLU clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Venous Leg Ulcer (VLU)
MediWound Ltd216 enrolled25 locationsNCT06568627
Recruiting
Phase 4

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Venous UlcerDiabetic Foot UlcerUlcer+6 more
BioLab Holdings50 enrolled1 locationNCT07364630
Recruiting
Phase 4

A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

Diabetic Foot Ulcer (DFU)Venous Leg Ulcer (VLU)
HealthTech Wound Care150 enrolled10 locationsNCT07172893
Recruiting
Not Applicable

Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care

Diabetic Foot Ulcers (DFUs)Venous Leg Ulcers (VLUs)
Reprise Biomedical, Inc.20 enrolled2 locationsNCT06939673
Recruiting
Phase 4

Trial to Evaluate Cyclical Topical Wound Oxygen Therapy in the Treatment of Chronic Venous Leg Ulcers

Venous Leg Ulcer (VLU)
AOTI Ltd.212 enrolled1 locationNCT06754735
Recruiting

Reducing Skin Tone Inequities in Chronic Venous Insufficiency

Venous Leg Ulcer (VLU)Chronic Venous Insufficiency, CVIChronic Venous Insufficiency C2 or Higher+1 more
King's College London51 enrolled2 locationsNCT06798766
Recruiting
Phase 1Phase 2

Safety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg Ulcers

Diabetic Foot Ulcer (DFU)Venous Leg Ulcer (VLU)
Nicolò Brembilla18 enrolled1 locationNCT07048054
Recruiting
Phase 4

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

Venous Leg Ulcer (VLU)
Kerecis Ltd.150 enrolled1 locationNCT06693570
Recruiting

Evaluating the Durability of Closure for Venous Leg Ulcers

Venous UlcerVenous Leg UlcerVenous Leg Ulcer (VLU)+2 more
Kerecis Ltd.150 enrolled1 locationNCT06697925